image
Akebia Therapeutics, Inc. AKBA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.79
-3.76 %
$ 391 M
Market Cap
-8.14
P/E
BALANCE SHEET
242 M ASSETS
-31.30%
Growth Rates
1Year -31.30%
3Years -27.87%
5Years -24.67%
7Years -3.05%
10Years 21.43%
272 M LIABILITIES
-20.50%
Growth Rates
1Year -20.50%
3Years -11.78%
5Years -5.46%
7Years 2.31%
10Years 52.86%
-30.6 M EQUITY
-327.38%
Growth Rates
1Year -327.38%
3Years -3.96%
5Years -0.94%
7Years -5.44%
10Years -7.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Akebia Therapeutics, Inc.
image
Current Assets 118 M
Cash & Short-Term Investments 42.9 M
Receivables 39.3 M
Other Current Assets 35.9 M
Non-Current Assets 124 M
Long-Term Investments 0
PP&E 16 M
Other Non-Current Assets 108 M
Current Liabilities 99.9 M
Accounts Payable 14.6 M
Short-Term Debt 24 M
Other Current Liabilities 61.2 M
Non-Current Liabilities 172 M
Long-Term Debt 80.1 M
Other Non-Current Liabilities 92.3 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 42.9 90.5 149.8 228.7 147.4 104.6 70.2 187.3 49.8 32.8 21.2 1.6
Short Term Investments 0 0 0 40.0 0.2 217.0 247.6 73.0 88.7 76.1 11.3 0
Receivables 39.3 41.1 51.6 26.9 38.9 16.7 34.2 33.8 0 48 K 0 85.6 K
Inventory 15.7 21.8 38.2 61.0 116.3 114.2 1 0 0 0 0 0
Other Current Assets 20.2 32.9 33.1 14.9 6.6 31.4 12.7 2.2 5.1 3.1 0.7 0.5
Total Current Assets 118.1 184.9 272.0 371.4 309.5 468.3 358.4 296.3 141.0 110.5 33.4 2.2
PP&E 16.0 34.4 40.6 35.5 39.4 8.0 3.6 2.6 0.5 0.2 30.4 K 0
Intangible Assets 36.0 72.1 108.1 144.2 291.2 328.2 0 0 0 0 0 0
Goodwill 59.0 55.1 55.1 55.1 55.1 55.1 0 0 0 0 0 0
Long Term Investments 0 2.7 2.0 2.0 2.1 2.5 1.3 0 0 0 0 0
Other Long Term Assets 12.4 5.4 49.8 38.0 76.0 21.8 2.3 1.3 1.4 0.3 1.2 0
Other Assets 0 0 0 0 0 0 0 0 0 72 0 0
Total Assets 241.7 351.8 525.5 644.1 771.2 996.5 364.2 300.2 142.9 111.0 34.7 2.2
LIABILITIES
Accounts Payable 14.6 18.0 33.6 41.3 39.2 42.8 7.0 2.0 2.3 2.0 0.7 0.4
Short Term Debt 24.0 36.7 102.3 5.3 5.0 15.0 0 0 0 0 0 0
Other Current Liabilities 61.2 71.0 104.2 125.3 124.1 150.9 51.5 30.3 9.6 4.9 3.2 4.5
Total Current Liabilities 99.9 124.8 256.5 187.1 208.1 265.7 144.3 114.3 11.9 6.9 3.9 4.9
Long Term Debt 80.1 120.5 33.7 121.0 103.3 0 0 0 0 0 8 K 0
Deferred Tax Income 0 0 1.8 2.4 1.6 6.6 0.2 0 0 0 0 0
Other Liabilities 49.0 57.5 139.1 63.0 31.9 32.6 2.6 2.5 74 K 32 K 0 0
Total Liabilities 272.3 342.5 449.1 396.5 376.4 360.6 244.9 232.1 11.9 6.9 3.9 4.9
EQUITY
Common Stock 2 K 2 K 1 K 1 K 1 K 1 K 0 0 0 0 134 6
Retained Earnings (1 609.0) (1 552.9) (1 460.4) (1 177.5) (794.1) (514.4) (374.1) (297.1) (161.4) (100.7) (63.7) (59.6)
Other Accumulative Comprehensive Income/Loss 6 K 6 K 6 K 13 K 0 (0.3) (0.4) 42 K (0.2) 56 K 1.28 K 0
Total Equity (30.6) 9.3 76.5 247.6 394.8 635.9 119.3 68.1 131.0 104.1 30.8 (2.7)
Total Liabilities and Equity 241.7 351.8 525.5 644.1 771.2 996.5 364.2 300.2 142.9 111.0 34.7 2.2
SHARES OUTSTANDING
Common Shares Outstanding 187.5 182.8 165.9 138.5 118.4 116.9 43.5 37.7 26.5 15.4 19.3 10.1